Continued from Yesterday
Bigelow noted VGA is currently helping companies develop or commercialize medical foods for diabetes; metabolic syndrome; obesity; erectile dysfunction; and specialty areas, such as tinnitis (ringing of the ears). She added the market is trending toward obesity and weight-management foods, especially for individuals with more than one disease.
Metagenics has also researched and developed several medical foods to nutritionally manage these types of conditions, including type-2 diabetes, metabolic syndrome, inflammatory bowel disease and others. Many of its offerings incorporate UltraMeal® PLUS 360, reduced iso-alpha acids (RIAA) from hops and an extract from an acacia plant. “These ingredients have been shown, through extensive laboratory and clinical testing, to beneficially influence insulin activity—an important factor in many prevalent health conditions—by modifying kinase activity and cellular processes that support healthy body systems,” Minich said, adding UltraMeal PLUS 360 was recently part of the intervention in a multi-center clinical trial on metabolic syndrome. “Publication of this research is pending, but preliminary results indicate UltraMeal PLUS 360 in combination with a Mediterranean-style, low-glycemic-load diet was effective in improving key cardiovascular risk factors in adults with metabolic syndrome.”
Acasti Pharma’s Onemia™ is also intended for patients with metabolic disorders, but specifically for those who have a phospholipid omega-3 deficiency. According to the company, Onemia can help patients who suffer from hyperlipidemia, atherosclerosis, diabetes, rheumatoid arthritis (RA) and gastroenterology disorders.
Continued Tomorrow
http://www.naturalproductsinsider.com/articles/2010/10/medical-foods-between-a-rock-and-a-hard-place.aspx
http://www.depsyl.com/
http://back2basicnutrition.com/
http://bionutritionalresearch.olhblogspace.com/
Wednesday, April 20, 2011
Subscribe to:
Post Comments (Atom)

No comments:
Post a Comment